Hypoxia-inducible factor and target gene expression are decreased in patients with sepsis: Prospective observational clinical and cellular studies

Anesthesiology

Volumn 118, Issue 6, 2013, Pages 1426-1436

  Schäfer, Simon T ^a,b   Frede, Stilla ^b   Winning, Sandra ^b   Bick, Alexandra ^a   Roshangar, Paktis ^a   Fandrey, Joachim ^b   Peters, Jürgen ^a   Adamzik, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; ALPHA INTERFERON; CD11B ANTIGEN; CD18 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS;

AGED; BLOTTING, WESTERN; FEMALE; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS;

EID: 84878643641     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31828baa67     Document Type: Article

References (30)

1. Frede S, Berchnerpfannschmidt U, Fandrey J: Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol 2007; 435:403-19
2. Frede S, Stockmann C, Freitag P, Fandrey J: Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 2006; 396:517-27
3. Frede S, Stockmann C, Winning S, Freitag P, Fandrey J: Hypoxia-inducible factor (HIF) 1alpha accumulation and HIF target gene expression are impaired after induction of endotoxin tolerance. J Immunol 2009; 182:6470-6
4. Eltzschig HK, Carmeliet P: Hypoxia and inflammation. N Engl J Med 2011; 364:656-65
5. Bracken CP, Whitelaw ML, Peet DJ: The hypoxia-inducible factors: Key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2003; 60:1376-93
6. Lisy K, Peet DJ: Turn me on: Regulating HIF transcriptional activity. Cell Death Differ 2008; 15:642-9
7. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-6
8. Edbrooke DL, Minelli C, Mills GH, Iapichino G, Pezzi A, Corbella D, Jacobs P, Lippert A, Wiis J, Pesenti A, Patroniti N, Pirracchio R, Payen D, Gurman G, Bakker J, Kesecioglu J, Hargreaves C, Cohen SL, Baras M, Artigas A, Sprung CL: Implications of ICU triage decisions on patient mortality: A cost-effectiveness analysis. Crit Care 2011; 15:R56
9. Le Gall JR, Lemeshow S, Leleu G, Klar J, Huillard J, Rué M, Teres D, Artigas A: Customized probability models for early severe sepsis in adult intensive care patients. Intensive Care Unit Scoring Group. JAMA 1995; 273:644-50
10. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-63
11. Winning S, Splettstoesser F, Fandrey J, Frede S: Acute hypoxia induces HIF-independent monocyte adhesion to endothelial cells through increased intercellular adhesion molecule-1 expression: The role of hypoxic inhibition of prolyl hydroxylase activity for the induction of NF-kappa B. J Immunol 2010; 185:1786-93
12. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9
13. Winer J, Jung CK, Shackel I, Williams PM: Development and validation of real-time quantitative reverse transcriptase- polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999; 270:41-9
14. Kong T, Scully M, Shelley CS, Colgan SP: Identification of Pur alpha as a new hypoxia response factor responsible for coordinated induction of the beta 2 integrin family. J Immunol 2007; 179:1934-41
15. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 306:2594-605
16. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8
17. Berchner-Pfannschmidt U, Yamac H, Trinidad B, Fandrey J: Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 2007; 282:1788-96
18. Bauer P: Multiple testing in clinical trials. Stat Med 1991; 10:871-89; discussion 889-90
19. Westfall PH, Krishen A: Optimally weighted, fixed sequence and gatekeeper multiple testing procedures. J Stat Plan Inference 2001; 99:25-40
20. Leone M, Boutière B, Camoin-Jau L, Albanèse J, Horschowsky N, Mège JL, Martin C, Dignat-George F: Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 2002; 30:808-14
21. Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS: Leukocyte adhesion during hypoxia is mediated by HIF-1- dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci USA 2004; 101:10440-5
22. Li X, Stark GR: NFkappaB-dependent signaling pathways. Exp Hematol 2002; 30:285-96
23. Eckle T, Grenz A, Laucher S, Eltzschig HK: A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J Clin Invest 2008; 118:3301-15
24. Rosenberger P, Schwab JM, Mirakaj V, Masekowsky E, Mager A, Morote-Garcia JC, Unertl K, Eltzschig HK: Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 2009; 10:195-202
25. Ahmed A, Kojicic M, Herasevich V, Gajic O: Early identification of patients with or at risk of acute lung injury. Neth J Med 2009; 67:268-71
26. Levitt JE, Bedi H, Calfee CS, Gould MK, Matthay MA: Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest 2009; 135:936-43
27. Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J, Siffert W: ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J 2007; 29:482-8
28. Adamzik M, Frey UH, Möhlenkamp S, Scherag A, Waydhas C, Marggraf G, Dammann M, Steinmann J, Siffert W, Peters J: Aquaporin 5 gene promoter-1364A/C polymorphism associated with 30-day survival in severe sepsis. Anesthesiology 2011; 114:912-7
29. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P, Ohta A, Lentsch AB, Lukashev D, Sitkovsky MV: Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2007; 2:e853
30. Owings RA, Boerma M, Wang J, Berbee M, Laderoute KR, Soderberg LS, Vural E, Jensen MH: Selective deficiency of HIF-1alpha in myeloid cells influences secondary intention wound healing in mouse skin. In Vivo 2009; 23:879-84